The acquisition time of infection: A determinant of the severity of hepatitis C virus-related liver disease in renal transplant patients

Clinical Transplantation

Volumn 23, Issue 5, 2009, Pages 723-731

  Toz H ^a   Nart, D ^a   Turan, I ^b   Ersoz G ^b   Sezis M ^a   Asci G ^a   Ozkahya M ^a   Zeytinoglu A ^c   Erensoy, S ^c   Ok, E ^a  

^a Department of Pathology ^*  (Turkey)

^b Division of Gastroenterology   (Turkey)

^c EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hepatitis C virus; Liver histology; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN; HEPATITIS C ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; ASCITES; BRAIN DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER DISEASE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TIME;

ADULT; ALANINE TRANSAMINASE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; MALE; POSTOPERATIVE COMPLICATIONS; RNA, VIRAL; SURVIVAL RATE; TIME FACTORS;

EID: 70350143026     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01017.x     Document Type: Article

References (39)

1. Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001, 38:919.
2. Alivanis P, Derveniotis V, Dioudis C. Hepatitis C virus antibodies in hemodialysed and in renal transplant patients: correlation with chronic liver disease. Transplant Proc 1991, 23:2662.
3. Huang CC, Liaw YF, Lai MK, Chu SH, Chuang CK, Huang JY. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992, 53:763.
4. Morales JM, Campistol JM, Dominguez-Gil B. Hepatitis C virus infection and kidney transplantation. Sem Nephrol 2002, 22:365.
5. Roth D, Zucker K, Cirocco R. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994, 45:238.
6. Pol S, Legendre C, Saltiel C. Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation. J Hepatol 1992, 15:202.
7. Kamar N, Rostaing L, Selves J. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 2005, 5:1704.
8. Stempel CA, Lake J, Kuo G, Vincenti F. Hepatitis C--its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993, 55:273.
9. Breitenfeldt MK, Rasenack J, Berthold H. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002, 16:130.
10. Ynares C, Johnson HK, Kerlin T, Crowe D, MacDonell R, Richie R. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival: a 5- and 10-year follow-up. Transplant Proc 1993, 25:1466.
11. Pereira BJG, Wright TL, Schmid CH, Levey AS. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995, 60:779.
12. Legendre C, Garrigue V, Le Bihan C. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998, 65:667.
13. Mathurin P, Mouquet C, Poynard T. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999, 29:257.
14. Hanafusa T, Ichikawa Y, Kishikawa H. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998, 66:471.
15. Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991, 325:454.
16. Kroes AC, de Man RA, Niesters HG, Schalm SW, Weimar W, Balk AH. Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only. J Hepatol 1994, 21:1113.
17. Lim HL, Lau GK, Davis GL, Dolson GJ, Lau JY. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994, 106:248.
18. Chan TM, Wu PC, Lok AS, Lai CL, Cheng IK. Clinicopathological features of hepatitis C virus antibody negative fatal chronic hepatitis C after renal transplantation. Nephron 1995, 71:213.
19. Ok E, Unsal A, Celik A. Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipients. Nephrol Dial Transplant 1998, 13:3103.
20. Delladetsima I, Psichogiou M, Sypsa V. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study. Am J Kidney Dis 2006, 47:309.
21. Rao KV, Anderson WR, Kasiske BL, Dahl DC. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993, 94:241.
22. Kiyosawa K, Akahane Y, Nagata A, Furuta S. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol 1984, 79:777.
23. Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997, 51:981.
24. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991, 13:372.
25. Rao KV, Anderson WR. Liver disease after renal transplantation. Am J Kidney Dis 1992, 19:496.
26. Bouthot BA, Murthy B, Schmid CH, Levey AS, Pereira BJG. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implication for policies on organ procurement. Transplantation 1997, 63:849.
27. Ong JP, Barnes SD, Younissi ZM. Outcome of de novo hepatitis C virus infection in heart transplant patients. Hepatology 1999, 30:1293.
28. File E, Mehra M, Nair S, Dumas-Hicks D, Perrillo R. Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation. Transplantation 2003, 76:1096.
29. Pollard S. Calcineurin inhibition and disease recurrence in the hepatitis C virus positive liver transplant recipients. Liver Int 2004, 24:402.
30. Nanmoku K, Imaizumi R, Tojimbara T. Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus positive renal transplantation and the usefulness of interferon therapy. Transplant Proc 2008, 40:2382.
31. Fabrizi F, Bromberg J, Elli A, Dixit V, Martin P. Hepatitis C virus and calcineurin inhibition after renal transplantation. Aliment Pharmacol Ther 2005, 22:657.
32. Kairaitis LK, Gottlieb T, George CRP. Fatal hepatitis B virus infection with fibrosing cholestatic hepatitis following renal transplantation. Nephrol Dial Transplant 1998, 13:1571.
33. Zylberberg H, Carnot F, Mamzer MF, Blancho G, Legendre C, Pol S. Hepatitis C virus related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997, 63:158.
34. Delladetsima JK, Boletis JN, Makris F, Psichogiou M, Kostakis A, Hatzakis A. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Liver Transplant Surg 1999, 5:294.
35. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 2006, 21:299.
36. Akpolat T, Ari{dotless}k N, Günaydi{dotless}n M. Prevalence of anti_HCV among hemodialysis patients in Turkey: a multicentre study. Nephrol Dial Transplant 1995, 10:479.
37. http://www.tsn.org.tr/documents/registry/registry_2007_tr-en.pdf
38. Zeytinoǧlu A, Erensoy S, Abaci{dotless}oǧlu H. Nosocomial hepatitis C virus infection in a renal transplantation center. Clin Microbiol Infect 2002, 8:741.
39. Sayi{dotless}ner AA, Zeytinoǧlu A, Ozkahya M. HCV infection in hemodialysis and CAPD patients. Nephrol Dial Transplant 1999, 14:256.